ClinicalTrials.gov
ClinicalTrials.gov Menu

Implantable Device for Male Reproductive Sterilization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00335361
Recruitment Status : Unknown
Verified April 2007 by Shepherd Medical Company.
Recruitment status was:  Active, not recruiting
First Posted : June 9, 2006
Last Update Posted : April 6, 2007
Sponsor:
Information provided by:
Shepherd Medical Company

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The study is to evaluate a device for male reproductive sterilization and determine if this device is successful at blocking the sperm.

Ninety subjects from two centers in the United Stated will be followed closely for 24 months.

If you are someone interested in a vasectomy, you may be eligible to participate in this clinical study.


Condition or disease Intervention/treatment Phase
Male Sterilization Device: Intra Vas Device (IVD) Phase 1

Detailed Description:
This feasibility study is intended to collect pertinent clinical information on the use of the Shepherd Medical Intra Vas Device (IVD) necessary to support the design of a future pivotal study. The IVD is intended to occlude the vas deferens and thus accomplish male reproductive sterilization and to offer an additional method to vasectomy.

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Enrollment : 90 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Intra Vas Device (IVD) As A Means of Male Reproductive Sterilization A Single Armed Feasibility Study
Study Start Date : September 2006
Estimated Study Completion Date : September 2009
Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Successful IVD implantation with vas deferens occlusion at 6 and 24 months post-implant.
  2. The IVD consists of a tubular silicone plug that is inserted into the lumen of the vas deferens to block the flow of semen.
  3. IVD implantation does not require the need to sever or permanently damage the vas deferens like the Ligation/Excision, Clip devices, Cautery
  4. techniques or Fascial Interposition require. One major advantage of the IVD is that it
  5. does not require excision and removal of a portion of the vas. Implantation of the IVD
  6. allows the vas deferens to remain intact and not be permanently damaged.

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Subject desires to undergo a vasectomy.
  2. Freely consents to participate in the Study a
  3. Agrees to provide a semen sample at regularized periods for at least 30 months.
  4. Willing to use a redundant method of contraception until successful occlusion is confirmed.
  5. Agrees to provide follow-up information.
  6. Willing and able to understand and agree to follow all aspects of the procedures and Study requirements.
  7. At least 18 years of age.

Exclusion Criteria:

  1. Has a condition permanently or temporarily making participation in the Study inadvisable.
  2. Has a condition permanently or temporarily making a vasectomy inadvisable.
  3. Has had a previous successful/unsuccessful vasectomy.
  4. Has had an allergic reaction to silicone and/or ethylene.
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00335361


Locations
United States, Florida
Douglas G. Stein, MD, PA
Tampa, Florida, United States, 33613
United States, Louisiana
Regional Urology, LLC
Shreveport, Louisiana, United States, 71106
United States, Minnesota
Adult and Pediatric Urology
Sartell, Minnesota, United States, 56377
Sponsors and Collaborators
Shepherd Medical Company
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

ClinicalTrials.gov Identifier: NCT00335361     History of Changes
Other Study ID Numbers: G050215
NIH grant # R44HD046318
First Posted: June 9, 2006    Key Record Dates
Last Update Posted: April 6, 2007
Last Verified: April 2007

Keywords provided by Shepherd Medical Company:
Male Contraceptive Devices
Intra Vas Device (IVD)
Male Sterilization
 Vasectomy
Intra Vas Deferens Occlusion
Vas Occlusion

Additional relevant MeSH terms:
Disinfectants
Anti-Infective Agents